SU5416—besides a specific VEGFR inhibitor—has been reported to inhibit VEGF mRNA expression in ovarian cancer cells through the PI3K/AKT/p70S6K1 signaling pathway [104]. Here, AKT1 is linked to ovarian carcinoma.